12696 Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices 

Federal Register. 82 FR 7562, January 

18, 2017 (FRL–9957–75). 

7. EPA. Final Rule; Procedures for Chemical 

Risk Evaluation Under the Amended 

Toxic Substances Control Act. Federal 

Register. 82 FR 33726, July 20, 2017 

(FRL–9964–38). 

8. EPA. Summary of External Peer Review 

and Public Comments and Disposition 

for C.I. Pigment Violet 29 (PV29) 

(Anthra[2,1,9-def:6,5,10- 

d′e′f′]diisoquinoline-1,3,8,10(2H,9H)- 

tetrone). January 2021. https://

www.regulations.gov/document/EPAHQ-OPPT-2018-0604-0126. 

Authority: 15 U.S.C. 2601 et seq. 

Michael S. Regan, 

Administrator. 

[FR Doc. 2022–04672 Filed 3–4–22; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2018–0443; FRL–8850–02– 

OCSPP] 

Octamethylcyclotetra-siloxane (D4); 

Final Scope of the Risk Evaluation To 

Be Conducted Under the Toxic 

Substances Control Act (TSCA); Notice 

of Availability 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: In accordance with the Toxic 

Substances Control Act (TSCA) and 

implementing regulations, EPA is 

announcing the availability of the final 

scope of the risk evaluation to be 

conducted for octamethylcyclotetrasiloxane (D4) (Cyclotetrasiloxane, 

2,2,4,4,6,6,8,8-octamethyl-; Chemical 

Abstracts Service Registry Number 

(CASRN) 556–67–2), a chemical 

substance for which EPA received a 

manufacturer request for risk 

evaluation. The scope document 

includes the conditions of use, hazards, 

exposures, and the potentially exposed 

or susceptible subpopulations that EPA 

plans to consider in conducting the risk 

evaluation for this chemical substance. 

ADDRESSES: The docket, identified by 

docket identification (ID) number EPA– 

HQ–OPPT–2018–0443, is available 

online at https://www.regulations.gov or 

in-person at the Office of Pollution 

Prevention and Toxics Docket (OPPT 

Docket), Environmental Protection 

Agency Docket Center (EPA/DC), West 

William Jefferson Clinton Bldg., Rm. 

3334, 1301 Constitution Ave. NW, 

Washington, DC. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

open to visitors by appointment only. 

For the latest status information on 

EPA/DC services and docket access, 

visit https://www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

For technical information contact: 

Bethany Masten, Existing Chemical Risk 

Management Division, Office of 

Pollution Prevention and Toxics, 

Environmental Protection Agency 

(Mailcode 7404T), 1200 Pennsylvania 

Ave. NW, Washington, DC 20460–0001; 

telephone number: (202) 564–8803; 

email address: masten.bethany@

epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general and may be of interest to 

entities that manufacture (including 

import) a chemical substance regulated 

under TSCA (e.g., entities identified 

under North American Industrial 

Classification System (NAICS) codes 

325 and 324110). The action may also 

be of interest to chemical processors, 

distributors in commerce, and users; 

non-governmental organizations in the 

environmental and public health 

sectors; state and local government 

agencies; and members of the public. 

Since other entities may also be 

interested, the Agency has not 

attempted to describe all the specific 

entities and corresponding NAICS codes 

for entities that may be interested in or 

affected by this action. 

B. What is the Agency’s authority for 

taking this action? 

The final scope document is issued 

pursuant to TSCA section 6(b)(4)(D) and 

TSCA implementing regulations at 40 

CFR 702.41(c)(8). 

C. What action is the Agency taking? 

EPA is publishing the final scope of 

the risk evaluation for D4 under TSCA. 

Through the risk evaluation process, 

EPA will determine whether the 

chemical substance presents an 

unreasonable risk of injury to health or 

the environment under the conditions of 

use, in accordance with TSCA section 

6(b)(4). 

II. Background 

TSCA allows chemical manufacturers 

to request an EPA-conducted risk 

evaluation of a chemical substance 

under 40 CFR 702.37. On March 19, 

2020, EPA received a manufacturer 

request for a risk evaluation of D4 (Ref. 

1). On June 17, 2020, EPA opened a 45- 

day public comment period to gather 

information relevant to the requested 

risk evaluation. EPA granted the request 

on October 6, 2020, and subsequently 

initiated the scoping process for the risk 

evaluation for this chemical substance. 

Pursuant to 40 CFR 702.41(c)(7), EPA 

announced the availability of and 

sought public comment on the draft 

scope document for the risk evaluation 

to be conducted for D4 under TSCA (86 

FR 50347, September 8, 2021) (FRL– 

8850–01–OCSPP) (Ref. 2). 

The purpose of risk evaluation is to 

determine whether a chemical 

substance, or category of chemical 

substances, presents an unreasonable 

risk of injury to health or the 

environment, under the conditions of 

use, including an unreasonable risk to a 

relevant potentially exposed or 

susceptible subpopulation (15 U.S.C. 

2605(b)(4)(A)). As part of this process, 

EPA must evaluate both hazards and 

exposures for the conditions of use; 

describe whether aggregate or sentinel 

exposures were considered and the 

basis for consideration; not consider 

costs or other nonrisk factors; take into 

account, where relevant, likely duration, 

intensity, frequency, and number of 

exposures and describe the weight of 

the scientific evidence for hazards and 

exposures (15 U.S.C. 2605(b)(4)(F)). This 

process will culminate in a 

determination of whether the chemical 

substance presents an unreasonable risk 

of injury to health or the environment 

under the conditions of use (15 U.S.C. 

2605(b)(4)(A); 40 CFR 702.47). 

III. Information and Comments 

Received on the Draft Scope 

In the Federal Register of September 

8, 2021 (Ref. 2), EPA announced the 

availability of the draft scope document 

for the risk evaluation to be conducted 

for D4 under TSCA and invited public 

comments on EPA’s draft scope 

document, including additional data or 

information relevant to the chemical 

substance or that otherwise could be 

useful to the Agency in finalizing the 

scope of the risk evaluation. To the 

extent that comments provided 

information on conditions of use, as 

well as other elements of the draft scope 

document, those comments and other 

submitted information (e.g., relevant 

studies, assessments, information on 

degradation products, and information 

on conditions of use) were used to 

inform revisions to the draft scope 

document and may be considered in 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices 12697 

subsequent phases of the risk evaluation 

process. 

EPA received six unique submissions 

for D4, including comments from 

potentially affected businesses or trade 

associations, environmental and public 

health advocacy groups, and one 

member of the general public. 

Comments addressed the overall 

approach to the risk evaluation process 

(e.g., collection, consideration, and 

systematic review of relevant 

information), the specific elements of 

the scope document (e.g., hazard, 

exposure, and potentially exposed or 

susceptible subpopulations), 

information specific to the chemical 

substance (e.g., relevant studies, 

assessments, degradation products, and 

conditions of use), and topics beyond 

the draft scope document phase of the 

process (e.g., risk management). EPA 

considered those comments, as 

applicable and appropriate, in 

developing the final scope document. 

Concurrently with the publication of the 

final scope document, EPA is 

publishing a response to comments 

document that contains a 

comprehensive summary of and 

response to public comments received 

on the D4 draft scope document. The 

comprehensive response to comments 

document is available in the docket 

EPA–HQ–OPPT–2018–0443 (Ref. 3). 

IV. References 

The following is a listing of the 

documents that are specifically 

referenced in this Federal Register 

notice. The docket for this action 

includes these documents and other 

information considered by EPA, 

including documents that are referenced 

within the documents that are included 

in the docket. For assistance in locating 

these referenced documents, please 

consult the technical person listed 

under FOR FURTHER INFORMATION

CONTACT. 

1. EPA. Octamethylcyclotetra-Siloxane (D4); 

Manufacturer Request for Risk 

Evaluation Under the Toxic Substances 

Control Act (TSCA); Notice of 

Availability and Request for Comments. 

Federal Register. (85 FR 36586, June 17, 

2020) (FRL–10010–49). 

2. EPA. Octamethylcyclotetra-Siloxane (D4); 

Draft Scope of the Risk Evaluation to be 

Conducted Under the Toxic Substances 

Control Act (TSCA); Notice of 

Availability and Request for Comments. 

Federal Register. (86 FR 50347, 

September 8, 2021) (FRL–8850–01– 

OCSPP). 

3. EPA. EPA Response to Public Comments 

Received on the Draft Scope of the Risk 

Evaluation for Under the Toxic 

Substances Control Act (TSCA) for 

Octamethylcyclotetra-siloxane 

(Cyclotetrasiloxane, 2,2,4,4,6,6,8,8- 

octamethyl-) (D4) CASRN 556–67–2 

(March 2022). 

Authority: 15 U.S.C. 2601 et seq. 

Michael S. Regan, 

Administrator. 

[FR Doc. 2022–04676 Filed 3–4–22; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

[MB Docket No. 22–76; FCC DA 22–187; 

FR ID 74348] 

Application of The Marion Education 

Exchange for Renewal of License for 

Station WWGH–LP, Marion, Ohio 

AGENCY: Federal Communications 

Commission. 

ACTION: Notice. 

SUMMARY: This Hearing Designation 

Order, Notice of Opportunity for 

Hearing, and Notice of Apparent 

Liability for Forfeiture (Order) 

commences a hearing to determine 

whether The Marion Education 

Exchange (MEE) has committed 

violations of the Communications Act of 

1934, as amended (Act) and/or the rules 

and regulations (Rules) of the Federal 

Communications Commission 

(Commission), and, as a consequence, 

whether MEE’s application (Renewal 

Application) to renew the license of low 

power FM radio station WWGH–LP, 

Marion, Ohio (Station) should be 

granted or denied pursuant to section 

309(k) of the Act, and whether a 

forfeiture should be imposed against 

MEE. 

DATES: Persons desiring to participate as 

parties in the hearing shall file a 

petition for leave to intervene not later 

than April 6, 2022. 

ADDRESSES: File documents with the 

Office of the Secretary, Federal 

Communications Commission, 45 L 

Street NE, Washington, DC 20554, with 

a copy mailed to each party to the 

proceeding. Each document that is filed 

in this proceeding must display on the 

front page the docket number of this 

hearing, ‘‘MB Docket No. 22–76.’’ 

FOR FURTHER INFORMATION CONTACT: 

Albert Shuldiner, Media Bureau, (202) 

418–2721. 

SUPPLEMENTARY INFORMATION: This is a 

summary of the Hearing Designation 

Order, Notice of Opportunity for 

Hearing, and Notice of Apparent 

Liability for Forfeiture (Order), MB 

Docket No. 22–76, FCC DA 22–187, 

adopted and released February 23, 2022. 

The full text of the Order is available 

online by using the search function for 

MB Docket No. 22–76 on the 

Commission’s ECFS web page at http:// 

apps.fcc.gov/ecfs/. 

Summary of the Order 

1. MEE was registered with the State 

of Ohio as a non-profit corporation on 

May 2, 2019, with Shawn Craft as the 

registered agent. On May 9, 2019, MEE 

and Marion Midget Football (MMF)— 

the Station’s former licensee—filed an 

application for Commission consent to 

the pro forma assignment of the 

Station’s license from MMF to MEE 

(Assignment Application). Therein, 

MEE indicated that ‘‘[t]here are no 

changes in the board members, only the 

name of the licensee.’’ MEE listed Patti 

Worcester (Worcester), Martha Maniaci 

(Maniaci), Mary Ann Stolarczyk 

(Stolarczyk), Betty Compton (Compton), 

and Marge Hazelett (Hazelett) as its 

board members, and indicated each had 

20 percent voting rights. We granted the 

unopposed Assignment Application on 

May 21, 2019. In the course of this 

license renewal proceeding, we have 

learned that Compton died on 

November 7, 2016, more than two years 

before MEE filed the Assignment 

Application that listed her as one of five 

existing and continuing members of 

MEE’s board. 

2. On May 28, 2019, MEE filed a pro 

forma transfer of control application 

(Transfer Application). MEE reported 

that ‘‘Worcester has decided to retire 

and voluntarily transfers her position to 

Shawn Craft.’’ We granted the 

unopposed Transfer Application on July 

11, 2019. 

3. On June 6, 2020, MEE filed the 

Renewal Application. Spencer Phelps 

(Phelps) then filed an Informal 

Objection. Phelps alleged that MEE had 

misrepresented its board composition in 

the Assignment Application. Phelps 

stated that the board members of MEE 

were ‘‘completely different people’’ than 

those MEE listed in the Assignment 

Application, and argued that MEE’s 

statement in that application that there 

were ‘‘no changes in the board 

members, only the name of the 

licensee’’ was false. To support his 

claim, Phelps submitted copies of 

corporate materials that MEE had filed 

with the State of Ohio. The corporate 

materials did not list Worcester, 

Maniaci, Stolarczyk, Compton, or 

Hazelett, the names listed in the 

Assignment Application. Instead, they 

listed four different individuals: Shawn 

Craft (Craft), Linda Sims (Sims), Glenn 

Coble (Coble), and Terry Tackett 

(Tackett). 

4. MEE did not respond to the 

Informal Objection. Accordingly, we 


khammond on DSKJM1Z7X2PROD with NOTICES